Faculty-Mhe

Meet Our Faculty & Their Research

This research-driven environment strengthens graduates' readiness for leadership roles in health economics, health policy planning, and healthcare management.

Dr. Naif Alotaibi

Dr. Naif Alotaibi

MD, DES, MSc
Focus of research

Dr. Naif H. AlOtaibi is a distinguished academic and expert in health economics, serving as a leading voice behind the Master of Science in Health Economics (MHE) program. With a strong foundation in health policy, pharmaceutical systems, and economic evaluation, his work bridges the gap between data driven research and real world healthcare decision making.

Recent publications
  1. Alotaibi NH, Alromaih S, Alshenaifi L, Alshareef N, Alkhashan R. The role of virtual reality in nasal procedures: a randomized controlled trial. Ann Med Surg (Lond). 2025 Nov 17;88(1):321-326. doi: 10.1097/MS9.0000000000004313. eCollection 2026 Jan.
  2. D Nepogodiev …. Alotaibi N. H. 30-day postoperative mortality and the effects of hospital preparedness during the COVID-19 pandemic: a pooled analysis of prospective international cohort studies. 2026. Lancet Reg Health Eur. . 2026 Jan 29;62:101566. doi: 10.1016/j.lanepe.2025.101566. eCollection 2026 Mar.
  3. Abdulrazaq Albilali, Naif H. Alotaibi, Abdulaziz Alfadley, Khalid M. Alqarni and Abdullah Alhajlah. Extensive locally invasive nasopharyngeal carcinoma involving 10 cranial nerves palsies: an interesting case report. Front Oncol. 2025 Jul 31;15:1545838. doi: 10.3389/fonc.2025.1545838. eCollection 2025.
  4. Alotaibi NH, Alrashed M, Drad MK, Abu-Safieh L, Almobarak AA, Baz B, et al. Isolated congenital anosmia: case report and literature review. Ear, Nose & Throat Journal. 2025;104(2_suppl):451S-454S.
  5. Alotaibi NH, Abaallkhail M, Almusa H, Alshenaifi LA, Alomairin A. Utilization of dupilumab in an immunocompromised patient with extensive allergic fungal rhinosinusitis unsuitable for surgical intervention: a case report. International Journal of Surgery Case Reports. 2025;126:110642.
Dr. C. Matthew Stewart

Dr. C. Matthew Stewart

MD, PhD
Focus of research

Dr. Stewart's research centers on patient safety, healthcare quality, clinical governance, and evidence based care delivery across complex health systems. His leadership in hospital epidemiology, health information management, and international system improvement aligns with the Faculty of Master of Science in Health Economics (MHE), strengthening expertise in health policy planning, health technology assessment, and value driven healthcare management in Saudi Arabia and globally.

Recent publications
  1. Reddy SC, Maroufi SF, Feghali J, Ahmed AK, Canales M, et al. The Relationship Between Extent of Resection, Tumor Recurrence, and Facial Nerve Outcomes in Vestibular Schwannoma Surgery: A Single-Institution Experience and Systematic Review. Journal of Neuro-Oncology. 2026;176(1):1–8.
  2. Reddy SC, Feghali J, Ahmed AK, Maroufi SF, Khalifeh JM, et al. Predictors of Postoperative Gustatory Disturbance and Gustatory Recovery Following Microsurgical Resection of Vestibular Schwannoma. Journal of Neuro-Oncology. 2026;176(2):133.
  3. Bessen SY, Tackett S, Peairs KS, C. Matthew Stewart, et al. Higher Electronic Health Record Burden Among Women Physicians in Academic Ambulatory Medicine. JAMIA Open. 2025;8(6):ooaf164.
  4. Bessen SY, Tackett S, Jenks CM, C. Matthew Stewart, Oliva-Hemker M, Lee JK. The Gender Gap in Academic Surgery: The Electronic Health Record. BMC Surgery. 2025;25(1):84.
  5. Sokol-Hessner L, C. Matthew Stewart, Sharma R, Zhang A, Gallagher TH, et al. Programs for Responding to Harms Experienced by Patients During Clinical Care. In: Making Healthcare Safer IV: A Continuous Updating of Patient Safety Harms. 2025.
Dr. Saleh AlTamimi

Dr. Saleh AlTamimi

MD
Focus of research

A Forbes ranked healthcare executive and CEO of Riyadh First Health Cluster, leading system wide transformation aligned with Vision 2030. With expertise in health policy, performance improvement, and large-scale health management, he bridges clinical practice and executive leadership. As Adjunct Associate Professor in the Master of Science in Health Economics (MHE) program, he mentors future leaders in health economics, policy planning, and evidence based health system transformation.

Recent publications
  1. Altamimi S, Khalil A, Khalaiwi KA, Milner RA, Pusic MV and Al Othman MA. Short-term late-generation antibiotics versus longer term penicillin for acute streptococcal pharyngitis in children. Cochrane Database of Systematic Reviews. 2012;8:CD004872.
  2. Altamimi S, Khalil A, Khalaiwi KA, Milner R, Pusic MV and Al Othman MA. Short versus standard duration antibiotic therapy for acute streptococcal pharyngitis in children. Cochrane Database of Systematic Reviews. 2009;1:CD004872.
  3. Alshowair A, Altamimi S, Alshahrani S, Almubrick R, Ahmed S, Tolba A, Alkawai F, Alruhaimi F, Alsafwani E, AlSuwailem F, Abdalla H and Abdel-Azeem A. Effectiveness of Case Manager Led Multi-Disciplinary Team Approach on Glycemic Control Amongst T2DM Patients in Primary Care in Riyadh: A Retrospective Follow-Up Study. Journal of Primary Care & Community Health. 2023;14:21501319231204592.
  4. Alshowair A, Altamimi S, Alruhaimi F, Tolba A, Almeshari A, Almubrick R and Abdel-Azeem A. Assessment of Primary Health Care Specialized Reference Clinics in Riyadh First Health Cluster: Outcome, Cost-Effectiveness and Patient Satisfaction. ClinicoEconomics and Outcomes Research. 2022;14:371-381.
  5. Alshowair A, Altamimi S, Alruhaimi FA, Alshahrani S, Alsuwailem F, Alkhaldi M, Abdalla H, Alkhuraiji FH, Alaqeel MS, Almureef SS, Alhawasy S and Abdel-Azeem A. Cost-Savings Associated with Multi-Disciplinary Team Approach for Reducing Macrovascular and Microvascular Complications in Patients with Type 2 Diabetes: A Predictive Model. ClinicoEconomics and Outcomes Research. 2024;16:211-223.
Dr. Ahmed H. Aljedai

Dr. Ahmed H. Aljedai

PharmD, MBA
Focus of research

Dr. Aljedai's research supports the Master of Science in Health Economics (MHE) through expertise in pharmacotherapy, transplant outcomes, and health policy leadership. As Assistant Deputy Minister for Therapeutic Affairs at Saudi Arabia's Ministry of Health, his work advances health technology assessments, pharmaceutical management, and evidence based commissioning aligned with national and international health economics priorities.

Recent publications
  1. Ahmed Al-Jedai, Hajer Almudaiheem, Wejdan Ibrahim, Said Aburas, Eid Almutairi, Maysa Tariq Eshmawi, Khalid Al Sulaiman, Essam Tawfik, Mohammed Al-Luhidan, Mohamed Alowairdhi, Nancy Awad, Rita Ojeil and Mohammed Ahmed Alshennawi. Shifting sands in Saudi Arabian healthcare system towards value based care: navigating the changing landscape. Front. Public Health, 18 March 2026 Sec. Health Economics Volume 14 - 2026 | https://doi.org/10.3389/fpubh.2026.1765428
  2. Al-Jedai A, Almudaiheem H, Al-Suweidan F, Jumah M, Al-Thobaiti A, et al. Budget Impact Analysis of Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis. Frontiers in Public Health. 2025;13:1713092.
  3. Mosli MH, Al-Bawardy B, AlAmeel T, Azzam NA, Bakkari SA, Alharbi OR, et al. Practical Guidelines on Medical Management of Adults with Moderate to Severe Inflammatory Bowel Disease. Saudi Journal of Gastroenterology. 2025.
  4. Alheggi A, Alhashem A, Alshihry HMH, Al-Khenaizan S, Alshammrie FF, et al. The Saudi National Policy and Protocol for Epidermolysis Bullosa. Risk Management and Healthcare Policy. 2025:3521–3538.
  5. Albanyan N, Altannir D, Tabbara O, Alrajhi AM, Aldemerdash A, Orfali R, et al. Parenteral Nutrition Management from the Clinical Pharmacy Perspective: Insights and Recommendations from the Saudi Society of Clinical Pharmacy. Pharmacy. 2026;14(1):16.
Dr. Sara Almunif

Dr. Sara Almunif

MD, MPH
Focus of research

A public health leader with a Doctorate of Public Health from New York University, their research strengthens the Master of Science in Health Economics (MHE) through expertise in health policy planning, data driven decision making, global health, and health systems transformation. Their work supports health technology policy, innovation, and evidence based commissioning across Saudi Arabia and international health systems.

Recent publications
  1. AlMunif S. The Patient Reported Indicators Survey (PaRIS) in Saudi Arabia: Measuring Patient-Reported Outcomes and Experiences in Adults Aged 18–44. Doctoral Dissertation, New York University. 2025.
  2. Bargo I, S. AlMunif, Bunyan R. Informing Health System Reform Through Patient Perspectives: Saudi Arabia's OECD PaRIS Survey Results. Poster presented at ISPOR Europe 2025; Glasgow, Scotland. 2025.
  3. AlMunif S. National Implementation of the OECD Patient Reported Indicator Surveys (PaRIS): Methodology and Data Collection Approach in Saudi Primary Care. Research contribution documented in OECD reporting and national health system implementation. 2025.
  4. AlMunif S. The Patient Reported Indicators Survey in Saudi Arabia – Implementation and Policy Implications. Policy Report, Center for Value in Health (Value in Health). Oct 2025.
  5. AlMunif S. Webinar: "Do Health Systems Deliver?" – Insights from Saudi Arabia's Participation in the OECD PaRIS Flagship Report. Webinar, Center for Value in Health. 2025.
Dr. Rita Ojeil

Dr. Rita Ojeil

HEOR & RWE Expert
Focus of research

Rita El Ojeil strengthens the Master of Science in Health Economics (MHE) through her leadership in Health Economics and Outcomes Research (HEOR), real world evidence, and health technology assessments. With 22+ years advising governments and the pharmaceutical industry, her work advances evidence-based commissioning, innovative access models, and value-driven health policy across Saudi Arabia and the MENA region.

Recent publications
  1. Al-Jedai AH, Almudaiheem HY, Alaama TY, Alsaman ASS, Bashiri FA, Rita Ojeil, et al. Advancing the First National Multi-Criteria Decision Analysis Framework in Saudi Arabia to Strengthen Healthcare Decision-Making. Value in Health Regional Issues. 2024;41:100–107.
  2. Hamad A, Al-Jedai A, Rita Ojeil, Al-Jazairi AS, AlAssy A, AlRuthia YS, et al. A Regional Roadmap for Sustainable Access to Specialty Pharmaceuticals Through Value-Based Healthcare Models in the GCC. Frontiers in Public Health. 2025;13:1667846.
  3. Hannawi S, Rita Ojeil, Alnaqbi A, Almarshoodi K, Alzaaroni E, Alzaaroni A, et al. A Phased Framework to Establish Health Technology Assessment Infrastructure for Emirates Health Services. Frontiers in Health Services. 2025;5:1662561.
  4. Alfadhel M, AlHashem A, Kurdi W, Tulbah M, AlGamdi S, Almannai M, et al.; Rita Ojeil. Adoption of Non-Invasive Prenatal Testing in Saudi Arabia: Clinical and Economic Considerations. The Application of Clinical Genetics. 2025;18:219–231.
  5. Al-Jedai AH, Almudaiheem HY, Al-Suweidan F, Jumah M, Al-Thobaiti A, Alzureiqan F, Abu Ras W, Al-Dosari FM, Malik YA, Dhopte P, Rita Ojeil, et al. Balancing innovation and affordability in relapsing-remitting multiple sclerosis: a budget impact analysis from Saudi Arabia. Frontiers in Public Health. 2025;13:1713092.
Dr. Abdulrazaq S. Al-Jazairi

Dr. Abdulrazaq S. Al-Jazairi

Pharm D, MBA
Focus of research

Dr. Al-Jazairi's research aligns with the Master of Science in Health Economics (MHE) through leadership in hospital pharmacy, formulary management, and clinical trials transformation in Saudi Arabia. His expertise supports health technology assessments, pharmaceutical policy, and evidence based commissioning, strengthening the Masters in Health Economics program's focus on health management, regulatory strategy, and value-driven healthcare decision making.

Recent publications
  1. Abu Esba LC, Yousef CC, Khan MA, Balhareth S, Al-Omar HA, Al-Najjar A, et al. Challenges in evaluation and reimbursement of drugs for rare diseases in Saudi Arabia: a Delphi expert consensus. Journal of Pharmaceutical Policy and Practice. 2025;18(1):2575040.
  2. Hamad A, Al-Jedai A, Ojeil R, Al-Jazairi AS, AlAssy A, AlRuthia YS, et al. Driving the future of value-based healthcare in the Gulf Cooperation Council. Frontiers in Public Health. 2025;13:1667846.
  3. Alyami SMA, Alzomor O, Hassan IS, AlShamrani M, Al-Jazairi AS, et al. Evidence-based guidelines for community-acquired pneumonia management. Annals of Thoracic Medicine. 2025;20(4):195-212.
  4. Al-Jazairi AS, Al-Gain R, Alrubayan NI, Almousa AF, Aldawood LM, et al. Specialty pharmacy implementation and patient outcomes. Journal of the American Pharmacists Association. 2025;65(1):102302.
  5. Al-Jazairi A, Almutham M, Alhashim S, Owaidah T. DOAC Anti-Xa testing value (.005), linking laboratory findings with patient-specific clinical parameters.
Dr. Mohammed Alluhidan

Dr. Mohammed Alluhidan

Health Economics
Focus of research

Dr. Mohammed Alluhidan brings national level expertise to the Master of Science in Health Economics (MHE) faculty. As Director of Health Economics at the Saudi Health Council, his research integrates evidence-based policy, health financing, and economic evaluation. His work in health technology assessment, patient outcomes, and healthcare efficiency strengthens the MHE program's focus on policy planning, system sustainability, and real world impact.

Recent publications
  1. EE701 The Economic Burden of Moderate and Severe Anxiety and Depression Symptoms in Saudi Arabia. Value in Health. 2025;28(12):S248.
  2. Spencer G, Alluhidan M, Reithinger R, Alsukait RF, Czapski R, Alamri A, et al. Assessing the economic cost of road traffic crashes in Saudi Arabia: potential savings from scaling up interventions. Frontiers in Public Health. 2025;13:1637609.
  3. Arulsamy K, Alfaisal A, Puri J, Alluhidan M, Altwaijri Y, Al-Habeeb A, et al. Economic burden of moderate and severe anxiety and depression symptoms among adults in Saudi Arabia: evidence from a cross-sectional web panel survey. BMJ Open. 2025;15(9):e092067.
  4. Lin G, Lin TK, Alluhidan M, Saber R, Hamza MM, Rakic S, Alfaisal A, et al. Evidence for building an integrated dementia healthcare system: a systematic review. Clinical Gerontologist. 2025:1-17.
  5. Finch MD, Parente ST, Grossbach AC, Zismer DK, Alluhidan M, Alfaisal A, et al. A Global Review of Accountable Care Organizations: Design Features and Lessons Learned. Medical Research Archives. 2025;12(12).
Dr. Hajer Almudaiheem

Dr. Hajer Almudaiheem

Pharmacoeconomics
Focus of research

Dr. Hajer Almudaiheem's research aligns closely with the Master of Science in Health Economics (MHE) faculty, focusing on pharmacoeconomics, medication safety, formulary management, and national drug policy. Her leadership in health technology assessments, cost efficiency analysis, and evidence based decision making supports health policy planning and pharmaceutical management across Saudi Arabia, enriching the MHE program's applied, policy driven academic framework.

Recent publications
  1. Alheggi A, Alhashem A, Alshihry HMH, Al-Khenaizan S, Alshammrie FF, et al. The Saudi National Policy and Protocol for Epidermolysis Bullosa. Risk Management and Healthcare Policy. 2025:3521–3538.
  2. Mosli MH, Al-Bawardy B, AlAmeel T, Azzam NA, Bakkari SA, Alharbi OR, et al. Practical guidelines on medical management of adults with moderate-to-severe inflammatory bowel disease. Saudi Journal of Gastroenterology. 2025. doi:10.4103.
  3. Al-Jedai AH, Almudaiheem HY, Alaama TY, Alsaman ASS, Bashiri FA, et al. Real-world evidence of Nusinersen treatment for patients with spinal muscular atrophy in the Kingdom of Saudi Arabia: Initial insights from the Saudi national spinal muscular… Saudi Medical Journal. 2025;46(12):1504.
  4. Al-Jedai A, Almudaiheem H, Al-Suweidan F, Jumah M, Al-Thobaiti A, et al. Balancing innovation and affordability in relapsing-remitting multiple sclerosis: a budget impact analysis from Saudi Arabia. Frontiers in Public Health. 2025;13:1713092.
  5. Fasseeh AN, Korra N, Aljedai A, Seyam A, Almudaiheem H, et al. Rare disease challenges and potential actions in the Middle East. International Journal for Equity in Health. 2025;24(1):1–14.
Dr. Maryam Alamodi

Dr. Maryam Alamodi

MBBS
Focus of research

Maryam Omar Alamodi contributes to the Master of Science in Health Economics (MHE) program as a Teaching Assistant while pursuing her Master of Public Health at Alfaisal University. A First Degree Honors MBBS graduate, her academic interests integrate public health research, health systems evaluation, and evidence-based clinical practice. She supports postgraduate teaching, course coordination, academic mentoring, and student research activities within the MHE program.

Recent publications
  1. Alamodi MO, et al. Prevalence and Influencing Factors of Self Medication During the COVID-19 Pandemic in the Arab Region: A Multinational Cross-Sectional Study. BMC Public Health. 2023;23:180.
  2. Eshaq AM, Flanagan TW, Hassan S-Y, Al Asheikh SA, Al-Amoudi WA, Santourlidis S, Hassan S-L, Alamodi MO, Bendhack ML, et al. Non-Receptor Tyrosine Kinases: Their Structure and Mechanistic Role in Tumor Progression and Resistance. Cancers. 2024;16(15):2754.